FRISON, LUCA
FRISON, LUCA
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements
2024-01-01 Bonifacio, Massimiliano; Scaffidi, Luigi; Miggiano, Maria Cristina; Facchinelli, Davide; Tosoni, Luca; Pezone, Sara; Griguolo, Davide; Ciotti, Giulia; Danini, Marco; Bernardelli, Andrea; Bresciani, Rita; Cavraro, Monica; Crosera, Lara; De March, Elena; Dell'Eva, Michele; Dorotea, Laura; Frison, Luca; Furlani, Lara; Gianesello, Ilaria; Lovato, Ester; Marchetti, Elena; Morelli, Gianluca; Mullai, Rikard; Pizzano, Umberto; Zoletto, Simone; Fanin, Renato; Krampera, Mauro; Trentin, Livio; Calistri, Elisabetta; Carli, Giuseppe; Binotto, Gianni; Tiribelli, Mario
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients.
2015-01-01 Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R.
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response
2015-01-01 Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; Marin, L; Scaffidi, Luigi; Frison, Luca; De Marchi, F; Krampera, Mauro; Semenzato, G; Fanin, R; Ambrosetti, Achille; Tiribelli, M.
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC.
2015-01-01 Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, G; De Marchi, F; Maino, E; Calistri, E; Bonalumi, Angela; Frison, Luca; Marin, L; Medeot, M; DE MATTEIS, Giovanna; Fanin, R; Semenzato, G; Ambrosetti, Achille; Tiribelli, M.
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure
2016-01-01 Bonifacio, Massimiliano; Binotto, G.; Tiribelli, M.; Scaffidi, Luigi; Iurlo, A.; Cibien, F.; Maino, E.; Guella, A.; Festini, G.; Minotto, C.; De Biasi, E.; Frison, Luca; De Marchi, F.; Medeot, M.; Bucelli, C.; Calistri, E.; Stulle, M.; Gherlinzoni, F.; Cortelezzi, A.; Fanin, R.; Semenzato, Giampietro; Krampera, Mauro; Pizzolo, Giovanni; Ambrosetti, Achille
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements | 1-gen-2024 | Bonifacio, Massimiliano; Scaffidi, Luigi; Miggiano, Maria Cristina; Facchinelli, Davide; Tosoni, Luca; Pezone, Sara; Griguolo, Davide; Ciotti, Giulia; Danini, Marco; Bernardelli, Andrea; Bresciani, Rita; Cavraro, Monica; Crosera, Lara; De March, Elena; Dell'Eva, Michele; Dorotea, Laura; Frison, Luca; Furlani, Lara; Gianesello, Ilaria; Lovato, Ester; Marchetti, Elena; Morelli, Gianluca; Mullai, Rikard; Pizzano, Umberto; Zoletto, Simone; Fanin, Renato; Krampera, Mauro; Trentin, Livio; Calistri, Elisabetta; Carli, Giuseppe; Binotto, Gianni; Tiribelli, Mario | |
| Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. | 1-gen-2015 | Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R. | |
| Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response | 1-gen-2015 | Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; Marin, L; Scaffidi, Luigi; Frison, Luca; De Marchi, F; Krampera, Mauro; Semenzato, G; Fanin, R; Ambrosetti, Achille; Tiribelli, M. | |
| Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. | 1-gen-2015 | Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, G; De Marchi, F; Maino, E; Calistri, E; Bonalumi, Angela; Frison, Luca; Marin, L; Medeot, M; DE MATTEIS, Giovanna; Fanin, R; Semenzato, G; Ambrosetti, Achille; Tiribelli, M. | |
| Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure | 1-gen-2016 | Bonifacio, Massimiliano; Binotto, G.; Tiribelli, M.; Scaffidi, Luigi; Iurlo, A.; Cibien, F.; Maino, E.; Guella, A.; Festini, G.; Minotto, C.; De Biasi, E.; Frison, Luca; De Marchi, F.; Medeot, M.; Bucelli, C.; Calistri, E.; Stulle, M.; Gherlinzoni, F.; Cortelezzi, A.; Fanin, R.; Semenzato, Giampietro; Krampera, Mauro; Pizzolo, Giovanni; Ambrosetti, Achille |